Research
A new study indicates that psilocybin-assisted therapy may reduce heavy drinking in patients with alcohol use disorder, with up to...
A unique study looks at how an ayahuasca ceremony may help rebuild community and heal trauma in a group of...
Field Trip is the only company exploring the therapeutic potential of a 4-HO-DiPT prodrug called FT-104. But how does it...
Compass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual property...
With the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on psychedelic treatments that are not...
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for...
In a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical. CEO Doug Drysdale explains why...
A new review finds that the chemical imbalance model of depression is wrong. What lessons can we learn about depression,...
Project Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian non-profit TheraPsil...
Does microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers...